🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 104 of 173

  1. US 8741589

    Monitoring two dimensions of diabetes pathogenesis

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8741306

    Kidney specific tumor vaccine directed against kidney tumor antigen G-250

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8741316

    Highly porous, recognitive polymer systems

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8734527

    Encapsulated kidney tissue

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8734808

    Isolation of a virus related to canine parvovirus-2 from a raccoon

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8735538

    Use of methanobactin

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8735440

    Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8735358

    Methods for treating cancer by regulation of tumor necrosis factor-alpha

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8735066

    Tumor suppressor designated TS10Q23.3

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8735057

    Fluorescence detection of poison oak oil

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8734853

    HDL particles for delivery of nucleic acids

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8734799

    Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8734836

    Methods and compositions for applying pharmacologic agents to the ear

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8734778

    Yeast-based vaccines as immunotherapy

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8728499

    Dendritic macroporous hydrogels prepared by crystal templating

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8729088

    Toll-like receptor modulators and treatment of diseases

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8729039

    Use of inhibitory oligonucleotides to treat autoimmune disease

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8728724

    Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8728472

    Antibodies that bind selectively to P25 and uses therefor

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8728458

    Combination anti-HIV vectors, targeting vectors, and methods of use

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8729248

    Sperm-specific cation channel, CATSPER2, and uses therefor

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8729047

    Compositions for inhibiting redox-sensitive GTPases

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8729028

    Noggin-derived peptide and use thereof

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8728806

    Methods and compositions related to Th-1 dendritic cells

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8728757

    Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8728532

    Ischemia/reperfusion protection compositions and methods of using

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8727775

    Dimer acid-derived dimethacrylates and use in dental restorative compositions

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8725266

    Method for stimulating retinal response using photoactive devices

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8722896

    Prokineticin receptor antagonists and uses thereof

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8722871

    VMP-like sequences of pathogenic borrelia species and strains

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8722716

    Isoxazole treatments for diabetes

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8722628

    Autophagy-inducing peptide

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8722616

    Anti-HIV peptides and methods of use thereof

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8722667

    Compositions and methods for inhibiting the proliferation of cells

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8715649

    Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8715645

    Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8716343

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8716258

    Regulation of metabolism by miR-378

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8716246

    Azuvirin peptides

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8716215

    Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8716017

    Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8715679

    Pili from Mycobacterium tuberculosis

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8715653

    Modulation of Rhamm (CD168) for selective adipose tissue development

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8709342

    Antimicrobial flush solutions

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8710030

    Phosphonate compounds

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8710017

    Human and mouse targeting peptides identified by phage display

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8709995

    Method for eliciting an immune response to human telomerase reverse transcriptase

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8709452

    Synthetic bone grafts

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.